Clinical Trials Sponsored by Ixaltis SA
Total 1044 results
-
Ixaltis SACompletedUrinary IncontinenceUnited States
-
XeltisActive, not recruitingEnd Stage Renal Disease | End Stage Renal Failure on DialysisItaly, Belgium, Latvia, Lithuania
-
XeltisEnrolling by invitationHeart Defect, CongenitalUnited States, Bulgaria, Malaysia, Poland
-
XeltisActive, not recruitingCongenital Heart DiseaseHungary, Malaysia, Poland
-
Ivantis, Inc.CompletedPrimary Open Angle Glaucoma | Cataract Unilateral Pending Extraction | Glaucoma, Open Angle, Pseudo-exfoliativeGermany, Italy, Netherlands, Spain
-
Ivantis, Inc.CompletedPrimary Open Angle GlaucomaMexico, Austria, Germany
-
XeltisRecruitingEnd-stage Renal DiseaseSpain, Italy, Belgium, Latvia, Portugal, Germany, Greece, United Kingdom, Poland
-
XeltisEnrolling by invitationMulti Vessel Coronary Artery DiseaseBelgium, Lithuania
-
XeltisWithdrawnHeart Defects, CongenitalHungary, Malaysia, Poland, Slovakia
-
Exactis InnovationRecruiting
-
Ivantis, Inc.CompletedOpen-angle GlaucomaSpain, United States, United Kingdom, Philippines, Colombia
-
Ivantis, Inc.CompletedPrimary Open Angle GlaucomaUnited States, Poland, United Kingdom, Spain, Canada, Germany, Italy, Mexico, Philippines
-
Ivantis, Inc.CompletedPrimary Open Angle Glaucoma | Pigmentary Glaucoma | Pseudoexfoliative GlaucomaUnited States
-
Ivantis, Inc.CompletedPrimary Open Angle Glaucoma | Pseudoexfoliative Glaucoma | Pigmentary Dispersion GlaucomaUnited States
-
Inmunova S.A.ExeltisTerminatedHemolytic-Uremic Syndrome | Pediatric Kidney Disease | Bloody Diarrhea | STEC, UnspecifiedArgentina
-
XeltisTechnomics ResearchCompletedHeart Defects, CongenitalRussian Federation
-
Axoltis PharmaACT4ALS networkNot yet recruiting
-
Exeltis TurkeyMonitor CROActive, not recruiting
-
Exactis InnovationKnight TherapeuticsCompleted
-
VivaltisCEISO; Human PhysioNot yet recruiting
-
Exeltis TurkeyMonitor CROCompletedTrichomonal Vaginitis | Bacterial Vaginosis | Candidal Vulvovaginitis | Mixed Vaginal InfectionsTurkey
-
Exeltis FranceInsud PharmaCompleted
-
Sankom SAInterMedService SA; Pharmaxi LLCUnknownChronic Venous InsufficiencyUkraine
-
Aptissen SANot yet recruiting
-
Aktiia SARecruitingHypertension | Blood Pressure | Heart RateSwitzerland
-
Firalis SANot yet recruiting
-
Amazentis SARecruitingHealthy | Healthy Aging | Healthy DietUnited States
-
Axalbion SARecruiting
-
Cellaion SAActive, not recruitingAcute on Chronic Liver FailureBelgium, Spain, France, Austria, Denmark, Latvia, Germany, Bulgaria, Poland, Estonia, Italy, Lithuania, North Macedonia, Slovakia
-
Teoxane SACompleted
-
Maxivax SAActive, not recruiting
-
Poxel SACompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Anokion SAActive, not recruitingRelapsing Remitting Multiple Sclerosis | Multiple Sclerosis (MS)United States
-
Amazentis SACompleted
-
Phargentis SACompleted
-
Cryotherapeutics SAWithdrawnAcute Coronary SyndromeDenmark, Sweden
-
Abionic SACompleted
-
Stalicla SACompletedAutism Spectrum DisorderUnited States
-
Stalicla SAWithdrawnAutism Spectrum DisorderUnited States
-
ObsEva SACompletedEndometriosisUnited States, Poland, Russian Federation, Ukraine
-
Sintetica SACompletedHealthy VolunteersAustria
-
Stalicla SACompletedAutism Spectrum DisorderUnited States
-
Sintetica SACompletedHealthy SubjectsSwitzerland
-
Firalis SAActive, not recruitingAMI PatientsFrance, Korea, Republic of
-
Spineart SATerminated
-
Anecova SACompletedEndometrial FluidSpain
-
Pharnext SACompletedPhase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) (PLEO-CMT)Charcot-Marie-Tooth Disease Type 1AUnited States, United Kingdom, Belgium, Canada, France, Netherlands, Spain, Germany